0001880064-25-000004.txt : 20251124 0001880064-25-000004.hdr.sgml : 20251124 20251121174012 ACCESSION NUMBER: 0001880064-25-000004 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251124 DATE AS OF CHANGE: 20251121 EFFECTIVENESS DATE: 20251124 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kamal Therapeutics, Inc. CENTRAL INDEX KEY: 0001880064 ORGANIZATION NAME: EIN: 861179522 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-564798 FILM NUMBER: 251509151 BUSINESS ADDRESS: STREET 1: 66 CLUBHOUSE DRIVE CITY: HINGHAM STATE: MA ZIP: 02043 BUSINESS PHONE: 857 222 4653 MAIL ADDRESS: STREET 1: 66 CLUBHOUSE DRIVE CITY: HINGHAM STATE: MA ZIP: 02043 FORMER COMPANY: FORMER CONFORMED NAME: Phoenicis Therapeutics, Inc. DATE OF NAME CHANGE: 20210825 D 1 primary_doc.xml X0708 D LIVE 0001880064 Kamal Therapeutics, Inc. 66 CLUBHOUSE DRIVE HINGHAM MA MASSACHUSETTS 02043 857 222 4653 DELAWARE Phoenicis Therapeutics, Inc. Corporation true 2020 Mark de Souza 66 Clubhouse Dr. c/o Kamal Therapeutics Hingham MA MASSACHUSETTS 02043 Executive Officer Director Philip Reilly 66 Clubhouse Dr. c/o Kamal Therapeutics Hingham MA MASSACHUSETTS 02043 Director John Parker 66 Clubhouse Dr. c/o Kamal Therapeutics Hingham MA MASSACHUSETTS 02043 Director Pharmaceuticals Decline to Disclose 06b false 2025-11-10 false true false 0 17307138 13807138 3500000 false 41 0 0 0 false Kamal Therapeutics, Inc. /s/Mark de Souza Mark de Souza President and Chief Executive Officer 2025-11-21